Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow (QoQ) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 506.56% |
| Jun 30, 2025 | -32.78% |
| Mar 31, 2025 | 176.49% |
| Dec 31, 2024 | 47.81% |
| Sep 30, 2024 | -144.49% |
| Jun 30, 2024 | 2,428.50% |
| Mar 31, 2024 | -84.69% |
| Dec 31, 2023 | -14.66% |
| Sep 30, 2023 | 183.13% |
| Jun 30, 2023 | 110.58% |
| Mar 31, 2023 | -312.29% |
| Dec 31, 2022 | 134.21% |
| Sep 30, 2022 | 57.36% |
| Jun 30, 2022 | -197.61% |
| Mar 31, 2022 | 364.36% |
| Dec 31, 2021 | -1,266.45% |
| Sep 30, 2021 | 103.36% |
| Jun 30, 2021 | -64.09% |
| Mar 31, 2021 | -628.24% |
| Dec 31, 2020 | -81.66% |